| Nov 20 |
Summit Therapeutics (SMMT) Hurt Bronte Capital. Here’s Why
|
| Nov 14 |
Merck Spends Up To $3.3 Billion In An Insurance Policy Against Summit Therapeutics
|
| Nov 10 |
TipRanks’ ‘Perfect 10’ Picks: 2 Top-Scoring Stocks for the Rest of 2024
|
| Nov 9 |
BioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential
|
| Nov 8 |
2 Hot Biopharma Stocks to Buy and Hold for 5 Years
|
| Nov 4 |
Why Summit Therapeutics Stock Was a Winner Today
|
| Nov 4 |
Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo
|
| Nov 4 |
Summit Therapeutics Leads the Parade of Big Gainers
|
| Nov 3 |
3 Magnificent Stocks Under $100 to Buy in November
|
| Oct 31 |
Summit Therapeutics Posts Wider-Than-Expected Loss in Q3, Nil Sales
|
